Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 135

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part II, Item 1
Chunk 135
---
-03-23
    2024-12-31

    0002028614
    
      us-gaap:CommercialPaperMember

    2024-12-31

    0002028614
    
      us-gaap:CommercialPaperMember

    2025-03-31

    0002028614
    
      srt:ChiefFinancialOfficerMember

    2025-03-31

    0002028614
    
      srt:ChiefFinancialOfficerMember

    2024-12-31

    0002028614
    
      dmaau:RelatedPartyLoansMember

    2025-03-31

    0002028614
    
      dmaau:RelatedPartyLoansMember

    2024-12-31

    0002028614
    
      dmaau:SponsorMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:OverAllotmentOptionMember

    2025-03-31

    0002028614
    
      dmaau:SubscriptionPromissoryNoteMember

    2025-03-31

    0002028614
    
      us-gaap:OverAllotmentOptionMember
      dmaau:UnderwritingAgreementMember

    2025-01-01
    2025-01-27

    0002028614
    
      us-gaap:OverAllotmentOptionMember
      dmaau:UnderwritingAgreementMember

    2025-02-18
    2025-02-18

    0002028614
    
      us-gaap:OverAllotmentOptionMember
      dmaau:UnderwritingAgreementMember

    2025-02-18

    0002028614
    
      us-gaap:CommonStockMember

    2024-01-01
    2024-12-31

    0002028614
    
      dmaau:RepresentativeSharesMember
      us-gaap:IPOMember

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:RepresentativeSharesMember
      us-gaap:OverAllotmentOptionMember

    2025-01-01